PDF
ePub
Citation
Print
INTRODUCTION
Parkinson disease is a representative neurodegenerative disease that occurs as dopamine production in the substantia nigra gradually diminishes, resulting in tremors, bradykinesia, rigidity, and unstable posture [12]. In addition to difficulty with daily activities, dysphagia also occurs frequently among patients with Parkinson disease [345]. This in turn causes aspiration pneumonia, which is one of the major causes of death among patients with Parkinson disease [67891011]. A variety of other factors, including functional conditions, oral hygiene, and accompanying diseases, may also bring about the occurrence of aspiration pneumonia among patients with Parkinson disease [12131415].
As with dysphagia, patients in the early stages of Parkinson disease often complain of difficulty in starting swallowing and eating due to mobility dysfunction, insufficient movement of saliva and food in the oral cavity, and labored lingual movements [16]. Furthermore, abnormal patterns of swallowing are observed, such as problems with epiglottic motion, slow recovery of the pre-swallow resting position, and delayed transfer and stasis of food [171819]. An increase in the oral transit time and tongue pumping [20], are frequently reported among the secondary symptoms relevant to the disease, along with bradykinesia and rigidity [1721].
The videofluoroscopic swallowing study (VFSS) is a standard tool for evaluating abnormalities in swallowing. With this test the risks of aspiration and complications with respiratory devices can be assessed. In addition, revisions to diet and compensatory strategies during swallowing can be established. Previous literature has reported that a high percentage of patients with Parkinson disease have a swallowing disability based on VFSS results [22]. Several studies using the VFSS with visual-perceptual parameters have evaluated the abnormalities of patients with Parkinson disease in the oral and pharyngeal phases. However, it is challenging to verify the pathological mechanism of dysphagia among patients with Parkinson disease using spatial and time variables [18]. Moreover, only a small portion of studies have discussed the relationship between these factors and aspiration pneumonia.
Some researchers have examined the relevance of aspiration by evaluating the functional dysphagia scale (FDS) scores of patients with stroke through the VFSS [23]. This scale is used to quantify functional dysphagia, such as oral movement, the defense mechanisms of the pharynx, and the amount of residue after swallowing. Few studies have applied this method to patients with Parkinson disease.
Therefore, the purpose of this study is to investigate which parameters and characteristics influence the occurrence of aspiration pneumonia, and to describe the correlation between the functional dysphagia scale and aspiration pneumonia in patients with Parkinson disease.
Go to : 
MATERIALS AND METHODS
Research subjects
Sixty-six patients with idiopathic Parkinson disease who were hospitalized in or visited the outpatient clinic at the Department of Physical Medicine and Rehabilitation and the Department of Neurology at Dong-A University Hospital from January 2013 to December 2014 were included in this study. The study only included patients on the regular, blend or soft oral diets. Patients with secondary Parkinson disease related to drugs, or infection that could cause fluctuating symptoms and neurodegenerative Parkinson syndrome (progressive supranuclear palsy, multiple system atrophy) were excluded. Those with other neurological defects or severe medical diseases which can influence dysphagia, such as stroke, dementia, congestive heart failure, chronic obstructive pulmonary disease, bronchiectasis, and having a tracheostomy were also excluded.
The present prospective study was approved by the Institutional Review Board of Dong-A University Hospital.
Evaluation method
The functional status and disease severity of all patients was investigated using the Schwab and England activities of daily living (S-E ADL) scale and modified Hoehn and Yahr (H&Y) staging [24]. The S-E ADL scale is a quantitative tool for evaluating the function of patients with Parkinson disease, where a higher score means a better functional status [24]. The modified H&Y staging assesses the symptoms of Parkinson disease by degrees from 0 to 5 to indicate the progress of the disease [24]. Furthermore, cognitive function was evaluated using the Korean version of Mini-Mental State Examination (K-MMSE).
The occurrence of aspiration pneumonia in subjects was followed for 3 months after the initial evaluation. Aspiration pneumonia was diagnosed by the following characteristics: fever accompanied by an increase in leukocytes, abnormal lung sounds, and abnormal findings in a chest X-ray.
Videofluoroscopic swallowing study
Each subject received the identical VFSS test with the modified Logemann's protocol [25]. This test was performed by experienced doctors in a fluoroscopic X-ray room in the Department of Physical Medicine and Rehabilitation. The subject sat laterally in front of the fluoroscopic tester and took a posture that is appropriate for a 4- to 5-second observation of anatomic structure, during which mouth and lip closure, and masticatory function and cooperation were briefly checked. The study subjects twice ate each of the following: soft blended food, normal regular food with standardized viscosity, and materials that were mixed with a liquid barium solution (barium sulfate; Solotop suspension). Afterward, the subjects were required to drink 100 mL of liquid barium that was diluted with water at a ratio of 1:3 so that invasion and aspiration could be assessed. A video recording was made of the overall test scene. The video was evaluated by three rehabilitation physicians and Rehabilitation who determined the penetration-aspiration score (PAS) and the FDS score. Each subject received the test during a 'drug-on' phase, that is, within 90–120 minutes of taking their anti-Parkinson disease medicine.
VFSS analysis
Functional dysphagia scale
To quantify the VFSS test results the FDS devised by Han et al. [23] was used, and the lip closure, food bolus formation, and masticatory function in the oral phase were assessed against three levels. The residue inside the oral cavity after swallowing was assessed against four levels. The transit time for what was thought to be the main food bolus during swallowing was measured. During the pharyngeal phase, laryngeal elevation and the decrease in epiglottic closing function, the delay in swallowing reflex, and the barium coating on the pharyngeal wall after swallowing were evaluated. Moreover, the amount of food bolus invasion into the nasal cavity, the amount of residue in the pyriform sinuses after swallowing, and the amount of residue in the vallecular fossa after swallowing were evaluated for classification on one of four levels. The delay in pharyngeal passing time was measured as the time required for the food bolus to pass the cricopharyngeal level from the lower corner of the mandible.
Penetration-aspiration scale
The PAS [26] is a tool used to evaluate tracheal invasion by a food bolus or liquid. It evaluates the swallowing function by classifying the symptoms that follow into one of eight levels, where a higher score means a poorer swallowing function.
Statistical analysis
SPSS ver. 18.0 for Windows software (SPSS Inc., Chicago, IL, USA) was used for statistical analysis in this study. The clinical characteristics and VFSS scores of the patients with Parkinson disease were analyzed with a nonparametric testing method using the Mann-Whitney U test. Patients were divided into two groups, one with aspiration pneumonia and one without aspiration pneumonia. Multiple logistic regressions were performed to control the gender, age, and other statistically significant variables to exclude the effects of factors that might have influenced the occurrence of aspiration pneumonia among the patients with Parkinson disease. A p-value of less than 0.05 was considered significant.
To calculate the sample size for logistic regression analysis, we used G*Power for Windows (ver. 3.1.9) with an effect size of 0.5, an alpha risk of 0.05, and a power of 0.80. The resulting calculated sample size was 53 patients. Considering a 10% dropout rate, the corrected sample size was 59 patients.
Go to :
RESULTS
The VFSS was performed in 66 patients with idiopathic Parkinson disease. Thirteen subjects (19.6%) with insufficient medical records, loss of follow-up, or other neurologic disease diagnosed in follow-up imaging studies were excluded. During the 3-month follow-up of 53 patients, 8 (15.0%) patients had aspiration pneumonia and 45 (84.9%) patients did not. In the evaluation of disease staging, function, and cognition among the study subjects, the group with aspiration pneumonia showed significantly higher H&Y staging (3.70±0.98 vs. 1.84±0.43; p=0.004), a lower S-E ADL scale (52.00±16.43 vs. 88.00±10.33; p=0.005), and a significantly lower K-MMSE score (21.50±4.17 vs. 26.40±3.87; p=0.048) than the group without aspiration pneumonia. The differences in gender and age between the two groups were not statistically significant (Table 1).
Based on the VFSS results, the group with aspiration pneumonia also showed significantly higher values of FDS (29.25±19.06 vs. 6.76±9.49; p=0.009) and PAS (5.37±2.82 vs. 2.23±1.84; p=0.047) than the group without aspiration pneumonia (Table 2).
Table 2
Dysphagia scale based on VFSS findings
Values are presented as mean±standard deviation.
VFSS, videofluoroscopic swallowing study; PAS, penetration-aspiration scale; FDS, functional dysphagia scale; oral phase, include section of FDS (lip closure, bolus formation, residue in the oral cavity, oral transit time); pharyngeal phase, include section of FDS (reduced laryngeal elevation and epiglottic closure, triggering of pharyngeal swallow delay, residue in the vallecular fossa, residue in the pyriform sinuses, coating of pharyngeal wall after swallow, pharyngeal transit time).
*p<0.05 by Mann-Whitney U test.
According to the multiple logistic regression analysis, the S-E ADL (odds ratio, 0.89; p=0.018) and the FDS (odds ratio, 1.10; p=0.043) were independently associated with the occurrence of aspiration pneumonia in patients with Parkinson disease (max-rescaled R2=0.78) (Table 3).
Go to :
DISCUSSION
Dysphagia is commonly observed among patients with Parkinson disease and the resulting aspiration pneumonia can be fatal. Although the symptoms of dysphagia and a variety of other factors that cause aspiration pneumonia should be considered, aspiration pneumonia was observed significantly more frequently in Parkinson disease patients with a low functional status. This result has been discussed in a number of studies [1415].
A previous study reported that a prolonged pharyngeal transfer time [16] among patients with Parkinson disease is relevant to the occurrence of aspiration pneumonia. This is consistent with the results in this study, in which a significantly longer transfer time in the pharyngeal phase was observed among the patients with aspiration pneumonia. Moreover, in this study, abnormalities of the oral phase, the amount of residue in the pyriform sinus, and the coating of barium on the pharyngeal wall after swallowing were also different between the two groups. Among patients with Parkinson disease, this problem is caused by a delay in the food bolus' transit time in the oral and pharyngeal phases [21], as well as bradykinesia, rigidity, and tongue movement abnormalities [2728]. The results of this study suggest that the frequency of aspiration pneumonia can increase due to a secondary process resulting from a decreased functional status and overall aggravation of the condition because of a poor oral diet.
Researchers previously found that a delay in the pharyngeal swallowing reflex is associated with aspiration pneumonia in Parkinson disease patients [2930]. In this study, the abnormality in the pharyngeal phase in the FDS, which is a delayed triggering of the pharyngeal swallowing reflex, was apparent, although there was no statistical significance (Table 2). We assume that this indicates that the FDS abnormalities in the pharyngeal phase can be detected at a relatively high level, even in patients without aspiration pneumonia.
The PAS of the VFSS showed a significantly higher score among the Parkinson disease patients who had aspiration pneumonia, but it had limitations when reflecting dysphagia in movement abnormalities, which is an important area of discomfort for patients with Parkinson disease. In the multiple logistic regression analysis in this study, only the S-E ADL scale and the FDS were statistically significant, with odds ratios of 0.89 and 1.10, respectively. These were most relevant to the occurrence of aspiration pneumonia when the S-E ADL scale was lower and the FDS was higher (Table 3). As previously stated, patients with Parkinson disease suffer with swallowing difficulties, which are caused by bradykinesia and rigidity. Therefore, the status assessment provides a better reflection of swallowing movement and function than airway invasion for swallowing abnormalities among patients with Parkinson disease. Functional status can also influence the occurrence of aspiration pneumonia in patients with Parkinson disease.
This study had several limitations. First, the number of patients with aspiration pneumonia was small (n=8). Second, we had a short follow-up period of 3 months. Although several studies had 6-month follow-up periods [16], follow-up over a longer term can have less significance in reflecting the condition and VFSS result a single point.
This study demonstrated that the occurrence of aspiration pneumonia among patients with Parkinson disease correlates with the FDS and the S-E ADL. Given that the FDS can quantitatively assess the functional problems of dysphagia, it is expected to be clinically effective in predicting the occurrence of aspiration pneumonia and selecting appropriate therapy options for dysphagia in patients with Parkinson disease.
Go to :
XML Download